Here’s what you should know:
1. Dr. Feinsod previously served as the company’s product development officer.
2. He succeeds Michael Goldstein, MD, who left the company to pursue other opportunities.
3. Dr. Feinsod holds several ophthalmology-based patents. He has also founded several companies, including Imagen Biotech, a company developing ophthalmology treatments for the unmet needs of those suffering from sight-threatening diseases.
4. Dr. Feinsod will be supported by the company’s clinical team.
More articles on leadership:
North Mississippi Medical Center Ambulatory Surgery Center RN continues full-time career at 81
Surgery Partners appoints Clifford Adlerz interim CEO
ASC leader to know: Don Phalen of Regent Surgical Health
